ClearPoint Neuro, Inc. Stock Analysis & AI Score
ClearPoint Neuro, Inc. (CLPT) has an ST Score of 35.0 (C-), driven by its Forecast (B+) and held back by its Profitability (D-). Analysts rate it Buy with a $23.50 price target (+60.8% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
ClearPoint Neuro, Inc. (CLPT) has an ST Score of 35.0 (C-), driven by its Forecast (B+) and held back by its Profitability (D-). Analysts rate it Buy with a $23.50 price target (+60.8% upside).
- Strongest
- ForecastB+
- Weakest
- ProfitabilityD-
All factor grades
- ForecastB+
- MomentumC+
- ValuationC
- Financial StrengthC-
- GrowthC-
- ProfitabilityD-
- Piotroski2/9
Contact
CLPT stock: frequently asked questions
What is CLPT's ST Score?
ClearPoint Neuro, Inc. (CLPT) has an ST Score of 35.0 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CLPT a buy, hold, or sell?
Analysts rate CLPT a Buy, with a price target of $23.50 (+60.8% vs the current price). Our ST Score grades it C- (35.0/100). The ST Score is a data-driven signal, not a recommendation.
What are CLPT's factor grades?
Valuation C, Profitability D-, Financial Strength C-, Momentum C+, Growth C-, Forecast B+.
What is CLPT's valuation grade?
ClearPoint Neuro, Inc. (CLPT) earns a valuation grade of C, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CLPT's growth grade?
ClearPoint Neuro, Inc. (CLPT) earns a growth grade of C-, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CLPT's profitability grade?
ClearPoint Neuro, Inc. (CLPT) earns a profitability grade of D-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CLPT's financial strength grade?
ClearPoint Neuro, Inc. (CLPT) earns a financial strength grade of C-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CLPT?
The average analyst price target for ClearPoint Neuro, Inc. (CLPT) is $23.50 from 3 analysts, which is +60.8% versus the recent price of $14.61.
What is CLPT's Piotroski score?
ClearPoint Neuro, Inc. (CLPT) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.